• The Association Between Exposure to Interferon-Beta During Pregnancy and Birth Measurements in Offspring of Women With Multiple Sclerosis 

      Burkill, Sarah; Vattulainen, Pia; Geissbuehler, Yvonne; Sabido Espin, Meritxell; Popescu, Catrinel; Suzart-Woischnik, Kiliana; Hillert, Jan; Artama, Miia; Verkkoniemi-Ahola, Auli; Myhr, Kjell-Morten; Cnattingius, Sven; Korhonen, Pasi; Montgomery, Scott; Bahmanyar, Shahram (Peer reviewed; Journal article, 2019-12-30)
      Background: Interferon-beta (IFN-beta) is a commonly used treatment for multiple sclerosis (MS). Current guidelines recommend cessation of treatment during pregnancy, however the results of past studies on the safety of ...
    • Pregnancy outcomes after exposure to interferon beta: a register-based cohort study among women with MS in Finland and Sweden 

      Hakkarainen, Katja Marja; Juuti, Rosa; Burkill, Sarah; Geissbühler, Yvonne; Sabidó, Meritxell; Popescu, Catrinel; Suzart-Woischnik, Kiliana; Hillert, Jan; Artama, Miia; Verkkoniemi-Ahola, Auli; Myhr, Kjell-Morten; Mehtälä, Juha; Bahmanyar, Shahram; Montgomery, Scott; Korhonen, Pasi (Journal article; Peer reviewed, 2020)
      Background Our aim was to estimate and compare the prevalence of adverse pregnancy outcomes among pregnant women with multiple sclerosis (MS) exposed to interferon beta (IFNB) and among women with MS unexposed to any MS ...